Citadel Advisors’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,344
| Closed | -$101K | – | 6618 |
|
|
2025
Q1 | $101K | Buy |
+10,344
| New | +$101K | ﹤0.01% | 5152 |
|
|
2024
Q3 | – | Sell |
-14,937
| Closed | -$94.6K | – | 6413 |
|
|
2024
Q2 | $94.6K | Buy |
+14,937
| New | +$94.6K | ﹤0.01% | 4978 |
|
|
2023
Q3 | – | Sell |
-28,028
| Closed | -$448K | – | 6295 |
|
|
2023
Q2 | $448K | Buy |
+28,028
| New | +$448K | ﹤0.01% | 3745 |
|
|
2022
Q3 | – | Sell |
-35,069
| Closed | -$393K | – | 6442 |
|
|
2022
Q2 | $393K | Buy |
+35,069
| New | +$393K | ﹤0.01% | 4371 |
|